BIOMODEX® is the leader in biorealistic haptic simulators and is based in Paris and Boston. Starting from standard patient-specific medical imaging, Biomodex has developed a unique and enhanced 3D printed solution for patient-specific rehearsal and physicians' advanced training, combining biomechanics and fluid dynamics and imaging properties. The Biomodex solution offers a tailored, end-to-end physician experience. The solution is fully integrated in both the imaging and procedural workflow, highly portable and easy to use. Image upload, ordering and quick delivery are facilitated through a web-based portal allowing customers to maintain their own portfolio of case cartridges. The solution is expected to result in reduced procedural and hospitalization costs and improved acute and chronic outcomes. Biomodex has successfully commercialized several products for neurovascular and structural heart applications and is fast expanding its product portfolio through the application of its core technologies.
Location: France, Ile-de-France
Employees: 11-50
Total raised: $15M
Founded date: 2015
Investors 3
| Date | Name | Website |
| - | LBO France | lbofrance.... |
| - | Agoranov | agoranov.c... |
| - | Wilco Acce... | wilco-star... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.04.2018 | Series A | $15M | - |
Mentions in press and media 4
| Date | Title | Description |
| 17.06.2024 | Ricoh’s new medical 3D printing facility to save time in the operating theater | Digital services company Ricoh USA has launched the RCOH 3D for Healthcare Innovation Studio, its new point-of-care additive manufacturing facility. Based at Atrium Health Wake Forest Baptist, a medical center in North Carolina, the facilit... |
| 27.04.2023 | Stratasys and Ricoh join forces to enhance clinical settings with on-demand 3D printed anatomic models | 3D printer OEM Stratasys and Ricoh, a multinational electronics firm headquartered in Japan, are working together to provide on-demand 3D printed anatomic models for clinical settings. Stratasys says by utilizing 3D printing technology, rea... |
| 17.12.2020 | BIOMODEX Announces Presentation of Data at SFNR 2020 Highlighting Benefits of Patient-Specific Rehearsals in Complex Unruptured Intracranial Aneurysms USA - English France - Français | |
| 07.06.2018 | Biomodex Raises $15M in Series A Funding | Biomodex, a Paris, France- and Boston, MA-based medical device company that uses 3D printing technology to develop patient-specific synthetic organs for pre-operative planning, raised an additional $15m in Series A funding. The round, which... |